Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA4 | P48058 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19937891 | 0.90 | GRIA4 (0.43) | GRIA4LMNATYRTSHRHDAC1 | |
| SCHEMBL18253211 | 0.85 | GRIA4 (0.51) | GRIA4LMNAHDAC8HDAC6TYR | |
| SCHEMBL5877385 | 0.81 | GRIA4 (0.51) | GRIA4LMNAHDAC8HDAC6TYR | |
| SCHEMBL1772745 | 0.78 | LMNA (0.49) | GRIA4LMNATYRTSHRHDAC1 | |
| SCHEMBL1834790 | 0.77 | ESR1 (0.40) | HDAC8HDAC6ESR1ESR2ADRA2A | |
| SCHEMBL1959897 | 0.77 | ESR1 (0.40) | HDAC8HDAC6ESR1ESR2ADRA2A | |
| SCHEMBL1835662 | 0.77 | ESR1 (0.40) | HDAC8HDAC6ESR1ESR2ADRA2A | |
| SCHEMBL3187891 | 0.77 | LMNA (0.45) | GRIA4LMNATYRADRA2AADRA2C | |
| SCHEMBL1660005 | 0.77 | GRIA4 (0.49) | GRIA4LMNATYRTSHRFFAR1 | |
| SCHEMBL13210867 | 0.77 | HDAC8 (0.42) | HDAC8HDAC6ESR1ESR2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065925-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065925-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | C1S, C1R, CRY1 | GRIA4 1342/4885LMNA 2438/4885HDAC8 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.